Testing effectiveness (Phase 2)Study completedNCT04405739
What this trial is testing
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
Who this might be right for
SARS-CoV 2
Ridgeback Biotherapeutics, LP 71